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Aim. Despite an incidence of parathyroid “incidentalomas” of 0.2%–4.5%, only approximately 135 cases have been reported in
the literature. We present eight patients in whom an incidental abnormal parathyroid gland was found during routine thyroid
surgery. We have reviewed the literature and postulate whether these glands could represent further evidence of a preclinical stage
ofprimaryhyperparathyroidism. Methods.Aretrospectiveanalysisofall236thyroidoperationsperformedbyasinglesurgeonwas
performed to identify patients in whom abnormal parathyroid tissue was removed at surgery. Results. 8/236 patients (3.39%) had
a single macroscopically abnormal parathyroid gland removed and sent for analysis. Seven patients were found to have histological
evidence of a parathyroid adenoma or hyperplasia. None of the patients had abnormal serum calcium detected preoperatively.
Postoperatively, four patients had normal calcium, three had temporary hypocalcaemia and one refused followup. No patients
had recurrent laryngeal nerve impairment. Conclusions. Despite the risk of removing a histologically normal gland, we believe that
when parathyroid “incidentalomas” are found during surgery they should be excised and sent for histological analysis. We have
found this to be a safe procedure with minimal morbidity to the patient. As the natural history of primary hyperparathyroidism
is better understood, these glands found in normocalcaemic patients may in fact represent the early or preclinical phase of the
disease. By removing them at the original operation, the patient is saved redo neck surgery with its high complication rate as or
when clinically apparent primary hyperparthryoidism develops in the future.
1.Introduction
Increasingly, patients with primary hyperparathyroidism are
being identiﬁed at an earlier, asymptomatic stage of the
disease. The reasons for this are multifactorial and include
the development of more sensitive parathyroid hormone
assays and increased screening of patients with measurement
ofPTHandserumcalcium,forexample,inaboneclinic.Itis
therefore, perhaps, not coincidental that endocrine surgeons
are identifying macroscopically abnormal parathyroid tissue
during thyroid operations in patients not known to have
calcium disorders.
Investigation of thyroid disease often includes ultra-
sonography of the neck and diagnostic blood tests, and
in some cases, coexistent thyroid and parathyroid disease
may be noted. Discovery of both pathologies preoperatively
involvesclinicalsuspicion,radiologicalﬁndings,orbiochem-
ical tests. Patients with the suspicion of PT disease can be
fully investigated prior to their thyroid operation and if
necessary have surgery to deal with both pathologies at the
same time.
However, in our practice, we have noted a series of
patients in whom parathyroid pathology was discovered
incidentally during thyroid surgery. These patients were
foundtohaveasinglemacroscopicallyabnormalparathyroid
gland on routine thyroid dissection without preoperative
suspicion of concomitant parathyroid disease.
We describe the cases encountered and review the litera-
ture on the subject.
2. Methods
A retrospective analysis of all 236 thyroid operations per-
formed by a single surgeon was performed to identify
patients in whom unsuspected abnormal parathyroid tissue2 ISRN Surgery
Table 1: Histological analysis of the parathyroid tissue excised.
Patient Age Sex Thyroid
operation
Preoperative






A 40 F Total 1.06/14.0 Adenoma 0.319g 15 ×10 ×15 Not done 1.96 Temporary
B 40 F Total 0.99/14.7 Adenoma/hyperplasia 0.501g 21 ×7 ×6 2.19 2.02 Pt refused
followup
C 30 F Total 2.63/8.8 Hyperplasia 0.163g 8 ×7 × 3 2.26 1.89 Temporary
D 66 M Total 46.3/5.7 No speciﬁc type 0.6g 30 ×8 ×5 Not done 2.31 No
E 50 F Total 0.01/12.1 Adenoma 0.319g 10 2.33 2.28 No
F 60 F Total 0.22/12.8 Adenoma <1g 17×7 ×5 2.32 1.80 Temporary
G 40 F Left
lobectomy 0.9/13.9 Normal histology Not stated 10 ×5 2.29 2.25 No
H 57 F Total 0.16/13.5 Adenoma/hyperplasia 0.844g 20 ×15 ×5 2.50 2.14 No
Normal ranges: TSH: 0.35–5.50mu/l, fT4: 9.4–22.7pmol/l, corr. Ca 2.15–2.60mmol/l.
was removed at surgery. When such a gland was found, the
remaining parathyroid glands were examined to ensure they
were macroscopically normal, and the abnormal gland was
excised and sent for histological examination.
3. Results
Between 2003 and 2008, our unit performed 236 thyroid
operations-either total thyroidectomy or lobectomy. In eight
patients (3.3%), a single macroscopically abnormal parathy-
roid gland was identiﬁed and excised during surgery. Seven
(2.96%) of these were subsequently conﬁrmed on histology
to have either a parathyroid adenoma or hyperplasia. Seven
patients were female, one was male, and the age range was
30–66 years. None of the patients had renal failure, a history
of irradiation to the neck, or was taking regular Lithium.
Three patients were subclinically thyrotoxic with depressed
TSH but normal T4 levels.
Six of our patients had serum calcium levels checked
preoperatively and these were all in the normal range,
measuring from 2.19 to 2.50mmol/l. Two patients did not
have preoperative calcium checks, and none of our patients
had preoperative parathyroid hormone (PTH) or vitamin
D levels, as parathyroid disease was not suspected before
surgery. Unfortunately, intraoperative PTH measurement is
not available in our institution, so these measurements could
not be taken.
Indications for thyroid surgery were pressure symptoms
with multinodular goitre in four patients (A, B, F, and H),
toxicmultinodulargoitreintwo(DandE),Graves’diseasein
one (C), and a colloid nodule in the other (G)—see Table 1.
The weight of the parathyroid glands removed ranged
from 163mcg to 844mcg and the size ranged from 8 × 7 ×
3mmto20×15 ×5mm.
Histopathological examination of the parathyroid tissue
showed adenoma in three patients (A, E, and F), hyperplasia
in one (C), features indistinguishable between adenoma and
hyperplasia in three patients (B, D, and H), and normal
parathyroid tissue in one patient (G). However, parathyroid
adenomas are usually diagnosed on macroscopic appear-
ances (single or double gland) rather than on histological
ﬁndings. None of our patients had more than one abnormal
g l a n dd e t e c t e do nf o u r - g l a n de x p l o r a t i o n .
Postoperatively, four patients had normal serum calcium
levels, and three required oral supplementary replacement
therapy for a few weeks postoperatively. One patient was
discharged on Calcichew and 1-alpha calciferol but has
refused postoperative followup or blood tests.
4. Discussion
Primary hyperparathyroidism is a relatively common disease
with incidences of between 1:200 and 1:1000 [1]. It is
more common in women and in patients with a history of
radiation to the neck [2].
Parathyroid disease is often diagnosed when a raised
calcium level is found on “routine” blood tests for other
medical problems. Usually, these patients are asymptomatic
or suﬀer from nonspeciﬁc symptoms of hypercalcaemia such
as fatigue, weakness, loss of appetite, nausea, and constipa-
tion. Less commonly nowadays, patients may present with
signiﬁcant renal and skeletal complications.
However, autopsy studies have found that 1.9–7.6% of
people have enlarged parathyroid glands without biochem-
ical or clinical abnormalities and a similar range has been
reported by endocrine surgeons [1–12].
A common time to discover these “incidentalomas” is at
the time of thyroid surgery when most surgeons attempt to
identify the parathyroid glands to ensure they remain well
perfused and are not excised with the thyroid specimen.
Published papers quote an incidence of 0.2% to 4.5% of
unsuspected parathyroid disease found at the time of thyroid
surgery in a normal population [1, 6]. Surprisingly, however,
only approximately 135 cases have been reported since the
ﬁrst case report in 1937—see Table 1.
If a surgeon encounters a macroscopically abnormal PT
gland during thyroid surgery, he faces a dilemma. Should he
remove the gland, presuming it to be pathological, or should
he leave it in situ so that full investigations can be performed
to conﬁrm that the patient has parathyroid disease? There
are risks in either scenario, and these must be balanced by
the surgeon when deciding what to do.ISRN Surgery 3
Table 2: Reported abnormal parathyroid glands discovered incidentally at thyroid surgery.
Incidentalomas/thyroid
operations
% total thyroid cases Postoperative
hypocalcaemia
1993 Hellman et al. [7] 8/594 1.35% Unknown
1992 Katz and Kong [1] 36/800 4.5% 2/36 permanent
1996 Carnaille et al. [8] 26/4697 0.6% 0/26
1981 Prinz et al. [2] 8/23 34.8% Irradiated pts 6/8 temporary
2001 Marchesi et al. [5] 3/1400 0.2% 1/3 temporary
2002 Denizot et al. [9] 12/739 1.6% 3h a dn o r m a l
histology Unknown
2005 Lokey et al. [6] 33/738 4.5% 6/33 temporary
2005 Schroﬀ et al. [10] 5/421 1.19% 0/5
2005 Whineray Kelly et al. [11] 1 Case report 1t e m p o r a r y
2008 Abboud et al. [12] 11/574 1.9% Unknown
The main risk of removing the gland is that the patient
may suﬀer from postoperative hypocalcaemia requiring
long-term calcium replacement. If this were to be a hyper-
functioning adenoma then this risk is probably justiﬁed as
the patient’s hyperparathyroidism is cured. However, if it
proves to be a normal gland, then the patient may have
postoperative morbidity without any clinical beneﬁt.
However, if an abnormal gland is left in situ, then
there is the risk of needing to perform “redo” surgery in
the future to remove it. This situation may arise because
the gland is overactive at the time of surgery and this
was not picked up preoperatively or because the disease
is in its preclinical or early phase and may develop into
overt hyperparathyroidism with time. Redo surgery carries
with it a much higher risk of complications, particularly of
bleeding, of damage to the recurrent laryngeal nerve (<1%
in primary surgery and up to 10% in redo surgery [13]), and
of postoperative hypocalcaemia due to inadvertent injury to
normal parathyroid tissue either at the original surgery or
redo operation.
As shown in Table 2, 10% of patients described in the
published “incidentaloma” papers suﬀered from temporary
postoperative hypocalcaemia and 1.5% required permanent
supplementation. These ﬁgures are no higher than those
seen in patients undergoing “routine” thyroid surgery,
where incidence of temporary hypoparathyroidism after
total thyroidectomy is quoted at 2–53% [14]. As there
are four parathyroid glands, careful surgery to identify
and preserve the remaining glands should not result in
signiﬁcantly increased risk of hypocalcaemia. Accidental
removal of normal parathyroid tissue during thyroid surgery
occurs in 6–21% cases of thyroid surgery, and for the most
part studies, have not reported an increase in postoperative
hypocalcaemia in such patients [15–19]. Treatment for
those who do become hypocalcaemic, either temporarily
or permanently, is relatively simple with oral calcium and
vitamin D if necessary.
5. NaturalHistory of the Disease
More is being discovered about the natural history of
primary hyperparathyroidism, and this information may
help in deciding the best course of action when discovering
“incidentalomas” during thyroid surgery.
In 1993, Hellman et al. examined the structure and
function of eleven enlarged parathyroid glands found in
nine patients undergoing thyroid surgery with normal
calcium levels. Although he found that only 8 out of 11
were microscopically abnormal, further examination with
monoclonal antibodies and measurement of cytoplasmic
calcium concentration showed that all but one were also
functionally abnormal [7].
Since then, two groups, Carnaille et al. and Abboud et
al., have examined the histological and biochemical features
of enlarged parathyroid glands found incidentally in normo-
calcaemic patients and compared them to glands removed
for overt primary hyperparathyroidism. “Incidentalomas”
were found to occur in younger patients, to be lighter
in weight, and to be biochemically and pathologically less
hyperfunctioning,suggestingthattheseglandsmayrepresent
an early stage of parathyroid disease [8, 12].
Development of accurate biochemical tests for parathy-
roid hormone, as well as increased awareness of skeletal
health with the use of bone proﬁling and density scans,
has led to an increased diagnosis of patients with primary
hyperparathyroidism. In the past, patients were diagnosed
when symptoms developed, but today, 80% of patients with
overt disease are asymptomatic [20].
Endocrinologists are noticing an increase in the number
of patients who have raised parathyroid hormones but nor-
mal calcium levels, and this leads to the question of whether
apreclinicalphaseofdiseaseexists[20–22].Suchpatientsare
labelled as having “normocalcaemic hyperparathyroidism”
in which calcium levels are normal but PTH is elevated.
For accurate diagnosis, it is important to exclude other4 ISRN Surgery
causes such as hypercalciuria, vitamin D deﬁciency, renal
impairment, and bone disease, for example, Paget’s disease
in such a biochemical scenario.
Unfortunately, in our case series, the patients had
unexpected ﬁndings of parathyroid pathology. This meant
that a thorough workup for parathyroid disease, such as
preoperative measurement of PTH and vitamin D levels, was
not performed. However, the nature of an incidentaloma
is that it is not suspected prior to its discovery, so all
of this information may not be available to the surgeon.
Intraoperative PTH measurement would have allowed us
to ascertain whether these patients had raised PTH levels
associated with the enlarged gland, but this was not a facility
available to us. Patients who suﬀer from Graves’ disease can
have macroscopically enlarged parathyroid glands secondary
to their thyroid dysfunction. Three out of patients had
subclinical thyrotoxicosis (one had Graves’ disease and two
had toxic nodules), but all three had free-T4 levels in the
lower half of the normal range. This could have been a
causative factor for the ﬁndings in some of our patients.
Given that coincidentally discovered abnormal parathy-
roid glands could represent early primary hyperparathy-
roidism, it is important to understand the progression
of surgically untreated mild hyperparathyroidism before
recommending routine removal of these glands.
The paper by Rubin et al. currently reports the longest
followup of patients with untreated primary hyperparathy-
roidism. 57 of 116 patients were originally randomised to no
surgery, and 49 of these patients were asymptomatic. At 10
years, the group reported the patients’ results and showed
evidence of disease progression in 25%. The followup
study, published in 2008, reported that at 15 years, this
had increased to 37% of asymptomatic patients developing
criteria for surgery [23, 24].
In another paper, 53 patients with mild asymptomatic
primary hyperparathyroidism were randomised to surgery
or routine followup. Those randomised to surgery had a
signiﬁcant beneﬁt on bone mineral density and quality of life
and psychological well-being scores [25].
Silverberg and Bilezikian studied patients who had raised
parathyroid hormone but normal calcium levels. Their
paper centred on the observation that many patients have
stable disease once primary hyperparathyroidism has been
diagnosed, raising the question as to when in the disease
course the biochemical and bony changes develop. They
propose that “normocalcaemic” hyperparathyroidism is in
fact the ﬁrst phase of a biphasic disease, and it is in
this period that the important biochemical and metabolic
changes occur [22].
6. Screening
Denizot et al. looked at screening for parathyroid disease
in patients undergoing thyroid surgery. Their group looked
prospectively at 748 patients due to have thyroid surgery
and screened them with preoperative serum calcium levels.
If these were high or at the higher end of normal, then
a parathyroid hormone level was measured. Nine patients
(1.2%) were positively screened and all had parathyroid ade-
nomas found at surgery. Of these, one-third needed speciﬁc
dissectiontoﬁndtheabnormalgland,anditwasdeemedthat
these glands would have been missed at “routine” surgery.
However, of the 739 patients who had negative screens,
12 were found to have “incidentalomas” and two patients
had a missed diagnosis of primary hyperparathyroid disease
discovered postoperatively [9].
Given what has been described above regarding a
preclinical or ﬁrst phase of hyperparathyroidism, maybe
the screening tool above could have been improved by
measuring parathyroid hormone rather than serum calcium.
This is much more costly, so, for this to be a viable option,
ﬁrm conclusions should probably be made regarding the
medical and cost beneﬁt of identifying these patients before
they proceed for thyroid surgery. If the model outlined by
Silverberg in 2003 is to be believed, then identifying these
patients in the ﬁrst phase and oﬀering them a surgical cure
will be to catch the disease in a destructive phase. Obviously,
it would remain to be seen if identifying the oﬀending
gland in its preclinical phase is possible with the current
localisation methods available.
7. Conclusions
Most endocrine surgeons will come across abnormal
parathyroid glands when performing thyroid surgery.
Despite the risk of removing a histologically normal gland,
we believe that when parathyroid “incidentalomas” are
found during surgery, they should be excised and sent
for histological analysis. We have found this to be a safe
procedure with minimal morbidity for the patient.
As the natural history of primary hyperparathyroidism
is better understood, the abnormal glands found in normo-
calcaemic patients could represent the early or preclinical
phase of the disease. However, our patient numbers are
small, and there are no “control” cases to assess whether
or not such patients might go on to develop primary
hyperparathyroidism.
By removing these glands at the original operation,
patients may avoid the need for redo neck surgery with
its high complication rate if clinically apparent primary
hyperparathyroidism were to develop in the future.
Perhaps we should be more astute in trying to detect this
patient population prior to surgery by keeping a high clinical
suspicion of coexisting disease or even screening patients for
parathyroid dysfunction prior to their thyroid surgery.
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